Back
ProShares UltraPro Dow30 Vs. Akero Therapeutics Industry Stock Comparison
Sell
50
UDOW
ProShares UltraPro Dow30
Last Price:
$96.25
Seasonality Move:
2.91%
Sell
42
AKRO
Akero Therapeutics
Last Price:
$52.83
Seasonality Move:
45.38%
Sell
50
ProShares UltraPro Dow30 (UDOW)
is a Sell
Is ProShares UltraPro Dow30 a Buy, Sell or Hold?
-
The current ProShares UltraPro Dow30 [UDOW] share price is $95.88. The Score for UDOW is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
UDOW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.57. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UDOW Stock Price Chart
What is ProShares UltraPro Dow30's stock price today?
-
The ProShares UltraPro Dow30 share price today is $95.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UDOW is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
UDOW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.46 | Buy |
| Relative Strength Index (14 RSI): | 61.09 | Buy |
| Chaikin Money Flow: | 24664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.17 - 95.53) | Buy |
| Bollinger Bands (100): | (75.99 - 95.81) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 49.06 | Sell |
| Chaikin Money Flow: | -3310 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.91 - 55.31) | Sell |
| Bollinger Bands (100): | (40.14 - 51.98) | Buy |
UDOW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.88 | Sell |
| 20-day SMA: | 91.18 | Buy |
| 50-day SMA: | 86.39 | Buy |
| 200-day SMA: | 93.44 | Buy |
| 8-day EMA: | 61.16 | Buy |
| 20-day EMA: | 31.81 | Buy |
| 50-day EMA: | 14.25 | Buy |
| 200-day EMA: | 3.78 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.46 | Buy |
| 20-day SMA: | 53.5 | Sell |
| 50-day SMA: | 49.2 | Buy |
| 200-day SMA: | 39.21 | Buy |
| 8-day EMA: | 51.9 | Sell |
| 20-day EMA: | 52.24 | Sell |
| 50-day EMA: | 49.79 | Buy |
| 200-day EMA: | 40.99 | Buy |
ProShares UltraPro Dow30 Earnings Growth & UDOW Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
ProShares UltraPro Dow30 Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||